More on TSHA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-33.3% Growth)
- Ratings (8.9 Score)

Upcoming Events

- Earnings (8/17/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Taysha Gene Therapies (NQ:TSHA)
Delayed: 5.82 +0.30 (5.43%)
Prev. Close $5.52  
Open$5.67 
52 Wk High$ 
52 Wk Low$ 
Day High$5.98 
Day Low$5.56 
P/E N/A  
EPS$ 
Volume269,613 

Friends, Peers and Foes (?): NGNE (more...)

Jul 21, 2026 06:38 AM Taysha Gene Therapies (TSHA) PT Raised to $13 at Goldman Sachs
Jul 10, 2026 06:55 PM Form 4 Taysha Gene Therapies, For: Jul 10 Filed by: Nagendran Sukumar
Jul 10, 2026 04:22 PM Form 144 Taysha Gene Therapies, Filed by: Nagendran Sukumar
Jul 2, 2026 04:19 AM Taysha Gene Therapies (TSHA) Reiterated at Market Outperform by Citizens
Jun 29, 2026 01:53 PM Taysha Gene Therapies (TSHA) PT Raised to $15 at Baird
Jun 25, 2026 04:26 PM Form 8-K Taysha Gene Therapies, For: Jun 24
Jun 25, 2026 04:24 PM Form 424B5 Taysha Gene Therapies,
Jun 25, 2026 04:01 PM Taysha Gene Therapies to present TSHA-102 data at 2026 Rett meeting
Jun 25, 2026 04:01 PM Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
Jun 24, 2026 10:33 PM Taysha Gene Therapies prices $200M public stock offering
View All Articles

Entities mentioned with TSHA

View All Entities